Evidence map›Paper›PMID 41899547›Full record

ReviewCancers2026

Nerve-Sparing in High-Risk Prostate Cancer: Advantages and Pitfalls of Current Strategies and Technologies.

Daniele Robesti, Pierluigi Russo, Giuseppe Fallara, Fernando Blank, Massimo Valerio, Ashutosh K Tewari, Francesco Montorsi, Guillaume Ploussard, Nilesh Patil, Alberto Martini

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniele RobestiUnit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Laboratory, Urological Research Institute, IRCCS San Raffaele Scientific Institute, 20133 Milan, Italy.ORCID 0000-0001-6486-2169
Pierluigi RussoDepartment of Urology, Fondazione Policlinico A. Gemelli IRCSS, 00168 Rome, Italy.ORCID 0000-0002-7789-9486
Giuseppe FallaraUnit of Urology, ASST Santi Paolo and Carlo, Milan, Italy.
Fernando BlankDepartment of Urology, University of Cincinnati, Cincinnati, OH 45267, USA.ORCID 0000-0002-4265-5334
Massimo ValerioDepartment of Urology, Geneva University Hospital, University of Geneva, 1011 Geneva, Switzerland.
Ashutosh K TewariDepartment of Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Francesco MontorsiUnit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Laboratory, Urological Research Institute, IRCCS San Raffaele Scientific Institute, 20133 Milan, Italy.
Guillaume PloussardDepartment of Urology, La Croix du Sud Hospital, 31130 Touoluse, France.
Nilesh PatilDepartment of Urology, University of Cincinnati, Cincinnati, OH 45267, USA.
Alberto MartiniDepartment of Urology, University of Cincinnati, Cincinnati, OH 45267, USA.ORCID 0000-0003-1272-7154

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

high risknerve sparingProstatic Neoplasmradical prostatectomysurgical marginstechnologies

Identifiers

PMID41899547
PMCPMC13025973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.